Trusted Supplier of 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone (CAS 32384-65-9)
We are a leading manufacturer and supplier of high-quality 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone, a critical intermediate for SGLT2 inhibitors. Procure this essential pharmaceutical raw material from a trusted source in China.
Get a Quote & SampleYour Reliable Source for Pharmaceutical Synthesis Intermediates
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
As a premier supplier in China, we offer super quality 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone with a guaranteed purity of 99.0% min. Our product meets USP, BP, EP, and FCC standards and is ideal for pharmaceutical manufacturers seeking a dependable partner for SGLT2 inhibitor synthesis. Buy this essential intermediate online for your research and development needs.
- High Purity 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone: Assured at 99% min for critical pharmaceutical applications.
- GMP SGS Certified Quality: We adhere to stringent manufacturing standards, ensuring product integrity.
- Competitive Pricing and Online Purchase Support: Making it easier for researchers and manufacturers to buy.
- Key Intermediate for SGLT2 Inhibitors: Essential for the synthesis of drugs like Dapagliflozin and Canagliflozin.
Why Choose Our Pharmaceutical Intermediates
Unwavering Quality Assurance
Our commitment to quality ensures that every batch of 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone meets rigorous international standards, vital for pharmaceutical applications and drug development.
Expert Manufacturing and Supply Chain
Leveraging advanced synthesis techniques, we are a reliable manufacturer and supplier, offering consistent availability and competitive prices for your bulk purchase requirements.
Directly Supports Diabetes Drug Synthesis
As a crucial intermediate for SGLT2 inhibitors, our product directly contributes to the production of life-changing medications for type 2 diabetes, making us a key partner for pharmaceutical companies.
Key Applications in Pharmaceutical Development
SGLT2 Inhibitor Synthesis
The primary application of our 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone is as a reagent in the synthesis of C-glucose containing trans cyclohexane, crucial for developing SGLT2 inhibitors.
Dapagliflozin Production
This compound serves as a vital intermediate in the preparation of Dapagliflozin, an important medication for treating type 2 diabetes.
Canagliflozin and Empagliflozin Intermediacy
It is also utilized as an intermediate for synthesizing other significant SGLT2 inhibitors like Canagliflozin and Empagliflozin, broadening its utility in diabetes treatment research.
General Pharmaceutical Research
Researchers can buy this high-purity chemical for various organic synthesis projects within the pharmaceutical and medicinal chemistry fields.